Pacific Edge

Pacific Edge Limited is a cancer diagnostic company specialising in the discovery and commercialisation of diagnostic and prognostic tests for the better detection and management of cancer. The company is currently developing and commercialising its range of Cxbladder bladder cancer tests globally through its wholly owned central laboratories in New Zealand and the USA. As it stands Pacific Edge has four proprietary, novel, accurate, molecular diagnostic products in-market providing actionable results for the better detection and management of urothelial cancer. These products have been extensively tested and validated in international multi-center clinical studies.

Company Details

Registered Office: Anderson Lloyd, Level 10, Otago House, Cnr Moray Place And Princes Street, Dunedin 9016

Postal Address: PO Box 56, Dunedin 9016

Telephone: +64-3-479-5800

Facsimile: n/a

Website: http://www.pacificedgedx.com

First Listed: 01/10/2003

Balance Date: 31 March

AGM: 27/07/2023

Directors and Executives

Tony Barclay

Independent Director

Chris Gallaher

Chairman

Grant Gibson

Chief Financial Officer

Mark Green

Independent Director

Anatole Masfen

Independent Director

Peter Meintjes

Chief Executive Officer

Sarah Park

Independent Director

Anna Stove

Independent Director

Bryan Williams

Independent Director

Announcements

Title	Date	Type
Annual Report 2024	Thu, Jun 27 2024 10:48 am	ANNREP
Cash Burn Slows; Coverage Catalysts in Focus	Tue, May 21 2024 08:32 am	FLLYR
SPH Notice - FirstCape Group Limited	Wed, May 01 2024 04:59 pm	SHINTR
SPH Notice - Jarden Securities Limited	Wed, May 01 2024 03:08 pm	SHINTR
Pacific Edge Full Year Result to be Announced 21 May 2024	Wed, May 01 2024 08:48 am	GENERAL
Clinical Utility of Cxbladder to Headline at AUA 2024	Tue, Apr 30 2024 01:52 pm	GENERAL
Quarterly Update - Cxbladder Test Volumes Steady in Q4 24	Tue, Apr 09 2024 09:05 am	GENERAL
SPH Notice - Salt Funds Management Limited	Fri, Mar 15 2024 04:08 pm	SHINTR
Pacific Edge Directors Give Notice of Retirement	Thu, Mar 14 2024 09:01 am	GENERAL
Cxbladder Test Volumes Correction	Mon, Jan 22 2024 04:40 pm	GENERAL

Major Holdings Announcements

Date	Name	No. Held	%	Current
17/04/23	ANZ New Zealand Investments Limited	58,714,600	6.18	7.25
18/01/23	Harbour Asset Management Limited an	127,988,137	14.78	15.79
10/12/21	Salt Funds Management Limited	48,114,089	6.95	5.94
30/09/21	Westpac Banking Corporation	52,810,384	8.14	6.70
03/12/20	AMP Capital Investors (New Zealand)	36,125,581	5.16	4.98
03/12/18	Jarden Partners Limited.	83,613,923	15.60	17.61
06/06/18	BNP Paribas Nominees (NZ) Limited a	20,612,121	5.47	4.42
05/07/17	Investment Services Group Limited	19,015,596	5.94	4.76
05/07/17	Devon Funds Management Limited	19,015,596	5.94	4.76
28/06/17	Harbour Asset Management & Jarden P	48,540,480	11.11	12.14
17/02/17	K One W One Limited	19,786,297	5.39	4.96
07/11/16	Superlife Trustee Nominees Limited,	2,033,501	5.99	0.53

Director’s Interests Announcements

Date	Name	No. Held	%	Details	Other
21/12/22	Peter Meintjes	185,000	-	-	-
22/03/22	Antony George Barclay	20,000	-	-	-
09/12/21	Bryan Williams	237,427	-	-	-
22/10/21	David Gregory Darling	4,611,562	-	-	-
22/10/21	Grant Edward Gibson	27,456	-	-	-
20/10/21	Sarah Park	58,591	-	-	-
06/10/21	Chris Gallaher	602,058	-	-	-
16/03/21	Anna Kate Stove	5,000	-	-	-
19/12/19	Kate Elizabeth Rankin	1,775,890	-	-	-
16/08/19	James Miller Suttie	190,568	-	-	-
30/05/19	John Duncan	900,333	-	-	-
30/06/16	Christopher John Swann	1,171,641	0.37	-	-

Analysts’ Forecasts

No forecasts available

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.

Last Updated: 08/06/2023